Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Biobusiness Briefs
  • Published:

Trial watch

Opportunities and challenges of the 2016 target landscape

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Examination of the target landscape in 2016.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyle Lafferty-Whyte.

Ethics declarations

Competing interests

All authors are full-time employees of Clarivate Analytics, which produces and sells the content and related products used to produce this analysis.

Supplementary information

Supplementary information S1 (box)

Data and analysis (PDF 111 kb)

Supplementary information

Supplementary information S2 (table) (XLSX 60 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lafferty-Whyte, K., Mormeneo, D. & del Fresno Marimon, M. Opportunities and challenges of the 2016 target landscape. Nat Rev Drug Discov 16, 10–11 (2017). https://doi.org/10.1038/nrd.2016.263

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.263

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research